0000899243-22-007203.txt : 20220222
0000899243-22-007203.hdr.sgml : 20220222
20220222165108
ACCESSION NUMBER: 0000899243-22-007203
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220217
FILED AS OF DATE: 20220222
DATE AS OF CHANGE: 20220222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALTSHULER DAVID
CENTRAL INDEX KEY: 0001550395
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 22658997
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-17
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001550395
ALTSHULER DAVID
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Global Research and CSO
Common Stock
2022-02-17
4
F
0
3439
232.51
D
53999
D
Common Stock
2022-02-18
4
S
0
986
229.22
D
53013
D
Common Stock
2022-02-18
4
S
0
1303
230.05
D
51710
D
Common Stock
2022-02-18
4
S
0
385
231.01
D
51325
D
Common Stock
2022-02-18
4
S
0
600
231.85
D
50725
D
Common Stock
2022-02-18
4
S
0
1038
233.27
D
49687
D
Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $229.22 (range $228.65 to $229.60).
Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $230.05 (range $229.65 to $230.59).
Open market sales reported on this line occurred at a weighted average price of $231.01 (range $230.66 to $231.43).
Open market sales reported on this line occurred at a weighted average price of $231.85 (range $231.67 to $232.01).
Open market sales reported on this line occurred at a weighted average price of $233.27 (range $232.91 to $233.50).
/s/ Sabrina Yohai, Attorney-in-Fact
2022-02-22